First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/histone Deacetylase Inhibitors As a Potential Therapeutic to Treat Alzheimer's Disease.
ACS Chemical Neuroscience(2024)
Key words
Alzheimer's disease,Neuroprotection,Multitarget Drugs,Glycogen Synthase Kinase 3 beta,Histone Deacetylase
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined